Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer

Published:2010-01 Issue:1 Volume:29 Page:8-18
ISSN:0277-1691
Container-title:International Journal of Gynecological Pathology
language:en
Short-container-title:International Journal of Gynecological Pathology

Author:

Duncan Timothy J.,Al-Attar Ahmad,Rolland Phil,Harper Sarah,Spendlove Ian,Durrant Lindy G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology,Pathology and Forensic Medicine

Reference52 articles.

1. CDK inhibitors: positive and negative regulators of G1-phase progression

2. p27 binds cyclin–CDK complexes through a sequential mechanism involving binding-induced protein folding

3. Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27

4. p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers

5. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix;Cancers;2021-04-06

2. Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma;Journal of Cell Communication and Signaling;2018-11-21

3. The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses;Oncotarget;2017-06-08

4. Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis;Molecular and Cellular Biology;2016-09-15

5. CRM-1 knockdown inhibits extrahepatic cholangiocarcinoma tumor growth by blocking the nuclear export of p27Kip1;International Journal of Molecular Medicine;2016-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3